Neurologists prescribe disease-modifying therapies (DMTs) immediately after a multiple sclerosis diagnosis to reduce relapse frequency. These include injectables, oral pills, and high-efficacy infusions like ocrelizumab. Doctors also use corticosteroids for acute flare-ups and specific medications to manage muscle spasticity or fatigue.
- Disease-modifying therapies: Started early to slow progression and prevent new brain or spinal cord lesions.
- Infusion treatments: Reserved for aggressive cases or when first-line oral medications fail to control activity.
- Relapse management: High-dose methylprednisolone speeds recovery during acute functional or mobility-impacting attacks.
- Symptom management: Muscle relaxants like baclofen or tizanidine address spasticity and improve daily walking speed.
Bookimed Expert Insight: While many clinics focus solely on medication, facilities like Altoa Beroun Rehabilitation Hospital in Prague integrate neurological rehabilitation with drug therapy. Dr. Milena Kolarova specializes in algiatry and pelvic floor therapy, which are vital for MS patients. Combining specialized rehabilitation with advanced DMTs often leads to better long-term functional outcomes than medication alone.
Patient Consensus: Patients note that starting treatments like interferons or Copaxone quickly is standard, though switching to advanced infusions often requires extensive paperwork. Many emphasize that while insurance covers most costs, staying below specific disability scores is often required for premium drug access.
